Maternal Antiretroviral Use During Pregnancy and Infant Congenital Anomalies: The NISDI Perinatal Study-Reference-Cited by-同舟云学术

Maternal Antiretroviral Use During Pregnancy and Infant Congenital Anomalies: The NISDI Perinatal Study

Published:2010-02 Issue:2 Volume:53 Page:176-185
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Joao Esau C,Calvet Guilherme A,Krauss Margot R,Freimanis Hance Laura,Ortiz Javier,Ivalo Silvina A,Pierre Russell,Reyes Mary,Heather Watts D,Read Jennifer S

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference28 articles.

1. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.;Szyld;AIDS,2006

2. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.;Kourtis;AIDS,2007

3. Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy.;Tuomala;J Acquir Immune Defic Syndr,2005

4. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?;Cotter;J Infect Dis,2006

5. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?;Thorne;Drug Saf,2007

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrase inhibitor drugs during pregnancy and congenital anomalies: A case/non‐case study from the global pharmacovigilance database VigiBase®;Pharmacology Research & Perspectives;2024-07-31

2. First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort;AIDS;2024-06-11

3. The Antiretroviral Pregnancy Registry: Three decades of prospective monitoring for birth defects;Pharmacoepidemiology and Drug Safety;2024-05-26

4. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis;BMC Pregnancy and Childbirth;2023-01-30

5. Epidemiology and Prevention of HIV Infection in Infants, Children, and Adolescents;Principles and Practice of Pediatric Infectious Diseases;2023